Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial

OBJECTIVE: To investigate whether intravenous immunoglobulin (IVIG) improves neurological outcomes in children with encephalitis when administered early in the illness. DESIGN: Phase 3b multicentre, double-blind, randomised placebo-controlled trial. SETTING: Twenty-one hospitals in the UK. PARTICIPA...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Matilda, Iro, Mildred, Sadarangani, Manish, Absoud, Michael, Cantrell, Liberty, Chong, Kling, Clark, Christopher, Easton, Ava, Gray, Victoria, Kneen, Rachel, Lim, Ming, Liu, Xinxue, Pike, Michael, Solomon, Tom, Vincent, Angela, Willis, Louise, Yu, Ly-Mee, Pollard, Andrew J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Paediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649701/
https://www.ncbi.nlm.nih.gov/pubmed/37945292
http://dx.doi.org/10.1136/bmjopen-2023-072134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649701/
https://www.ncbi.nlm.nih.gov/pubmed/37945292
http://dx.doi.org/10.1136/bmjopen-2023-072134

Ejemplares similares